CN Stock MarketDetailed Quotes
688193 Shanghai Rendu Biotechnology
- 25.08
- -0.11-0.44%
Trading Jul 29 14:48 CST
1.00BMarket Cap54.64P/E (TTM)
25.68High24.82Low1.22KlotVolume25.68Open25.19Pre Close3.07MTurnover0.40%Turnover Ratio121.75P/E (Static)40.00MShares52.4352wk High1.06P/B758.86MFloat Cap22.3052wk Low30.23Limit Up30.26MShs Float71.68Historical High20.15Limit Down3.41%Amplitude22.30Historical Low0.20Dividend TTM25.16Avg Price612.85lotAsk0.80%Div YieldTTM100Lot Size464.02lotBid
Shanghai Rendu Biotechnology Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 15.60%44.82M | -45.89%164.41M | -51.23%117.1M | -52.83%80.03M | -58.44%38.77M | 3.95%303.85M | 7.40%240.1M | 21.07%169.66M | 7.43%93.28M | 16.97%292.31M |
| Operating revenue | 15.60%44.82M | -45.89%164.41M | -51.23%117.1M | -52.83%80.03M | -58.44%38.77M | 3.95%303.85M | 7.40%240.1M | 21.07%169.66M | 7.43%93.28M | 16.97%292.31M |
| Total operating cost | -9.55%43.74M | -37.24%182.29M | -38.98%134.81M | -33.94%97.24M | -33.93%48.36M | 27.94%290.47M | 31.90%220.91M | 43.15%147.2M | 16.59%73.2M | 21.69%227.04M |
| Operating cost | 14.80%8.71M | -70.77%30.61M | -70.79%21.41M | -72.62%14.84M | -73.63%7.59M | 41.20%104.74M | 34.30%73.28M | 65.48%54.2M | 47.68%28.78M | 23.02%74.18M |
| Operating tax surcharges | 12.38%244.78K | -19.63%965.11K | -18.96%701.2K | -31.80%469.75K | -53.98%217.82K | 44.87%1.2M | 54.11%865.28K | 82.43%688.77K | 91.55%473.34K | -6.51%828.92K |
| Operating expense | -22.37%20.26M | -26.30%90.95M | -32.78%67.84M | -21.76%51.55M | -14.12%26.09M | 21.72%123.4M | 30.82%100.91M | 39.76%65.89M | 3.71%30.38M | 25.27%101.37M |
| Administration expense | 1.24%7.22M | -14.58%26.77M | -7.43%21.04M | 7.90%14.5M | 8.74%7.14M | 21.38%31.34M | 23.35%22.73M | 6.90%13.44M | -12.55%6.56M | 23.78%25.82M |
| Financial expense | -140.18%-2.87M | -84.95%-8.14M | -98.22%-5.89M | -61.20%-2.73M | -334.26%-1.2M | -197.77%-4.4M | -130.46%-2.97M | -123.61%-1.69M | 31.14%-275.62K | -1,531.46%-1.48M |
| -Interest expense (Financial expense) | -15.07%110.23K | 21.30%431.2K | 255.18%407.4K | 51.28%299.69K | 74.85%129.79K | --355.47K | -47.70%114.7K | 12.65%198.11K | -22.55%74.23K | ---- |
| -Interest Income (Financial expense) | -88.67%-2.56M | -106.18%-8.72M | -124.06%-5.6M | -54.72%-3.04M | -478.35%-1.35M | ---4.23M | -50.68%-2.5M | -80.11%-1.97M | 47.90%-234.17K | ---- |
| Research and development | 19.46%10.18M | 20.31%41.14M | 13.87%29.7M | 26.76%18.6M | 17.21%8.52M | 29.91%34.19M | 44.30%26.09M | 36.66%14.67M | 9.40%7.27M | 11.06%26.32M |
| Credit Impairment Loss | -34.53%-425.49K | 77.16%-629.91K | 87.29%-233.15K | 89.92%-220.06K | 42.94%-316.27K | -149.72%-2.76M | -63.81%-1.83M | -653.37%-2.18M | 39.80%-554.27K | -35.20%-1.1M |
| Asset Impairment Loss | 33.48%-357.33K | 49.82%-1.28M | -9.53%-853.9K | -72.86%-664.93K | -81.62%-537.19K | -1,177.57%-2.54M | -546.20%-779.62K | -241.29%-384.66K | -602.83%-295.77K | 56.98%-198.97K |
| Adjustment items of total operating cost | ---- | ---- | --0.01 | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | ||||||||||
| Fair value change income | 189.78%620.81K | -32.39%661.64K | ---335.36K | --651.77K | ---691.48K | --978.61K | ---- | ---- | --0 | --0 |
| Invest income | -65.78%974.19K | -17.01%6.92M | -5.07%6.59M | -2.05%3.31M | 287.18%2.85M | 586.95%8.34M | 941.16%6.94M | 687.39%3.38M | 541.50%735.3K | 12.49%1.21M |
| Asset deal income | ---- | -138.54%-53.51K | -139.90%-53.51K | ---- | ---- | -81.79%138.85K | -64.31%134.12K | 213.33%89.9K | --89.9K | 48.97%762.64K |
| Other revenue | 1,204.55%1.49M | 77.46%17.69M | -81.31%1.31M | -47.49%1.31M | --113.93K | 59.49%9.97M | 304.66%6.99M | 687.24%2.49M | --0 | 13.86%6.25M |
| Adjusted Items effecting operating profit | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 141.26%3.37M | -80.22%5.44M | -136.83%-11.28M | -149.59%-12.82M | -140.76%-8.18M | -61.90%27.51M | -46.81%30.64M | -31.38%25.85M | -13.97%20.06M | 4.42%72.19M |
| Add:Non operating Income | --33.03K | 3,197.41%135.38K | -99.97%1.45 | -99.98%1.11 | ---- | -99.35%4.11K | -99.17%5.35K | -99.16%5.35K | -99.17%5.35K | -55.58%636.34K |
| Less:Non operating expense | -77.32%33.61K | -1.77%815.06K | -40.24%495.38K | -50.58%150.27K | --148.21K | 116.82%829.73K | 127.11%828.99K | -11.18%304.06K | --0 | 19.12%382.69K |
| Total profit | 140.52%3.37M | -82.15%4.76M | -139.51%-11.78M | -150.75%-12.97M | -141.49%-8.32M | -63.17%26.68M | -48.49%29.82M | -32.71%25.55M | -16.03%20.07M | 3.13%72.44M |
| Less:Income tax cost | 82.88%-330.77K | -204.38%-3.5M | -156.69%-3.44M | -176.47%-2.78M | -159.29%-1.93M | -57.17%3.35M | -8.99%6.06M | -26.44%3.63M | -26.91%3.26M | -11.78%7.82M |
| Add:Adjusted items effecting net profit | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit | FLtoP3.7M | -64.60%8.26M | SL-8.34M | SL-10.19M | SL-6.39M | -63.89%23.33M | -53.62%23.75M | -33.64%21.92M | -13.54%16.81M | 5.28%64.62M |
| Net profit from continuing operation | 157.94%3.7M | -64.60%8.26M | -135.12%-8.34M | -146.50%-10.19M | -138.03%-6.39M | -63.89%23.33M | -53.62%23.75M | -33.64%21.92M | -13.54%16.81M | --64.62M |
| Net profit of parent company owners | 157.94%3.7M | -64.60%8.26M | -135.12%-8.34M | -146.50%-10.19M | -138.03%-6.39M | -63.89%23.33M | -53.62%23.75M | -33.64%21.92M | -13.54%16.81M | 5.28%64.62M |
| Earning per share | ||||||||||
| Basic earning per share | 156.25%0.09 | -66.13%0.21 | -129.58%-0.21 | -139.68%-0.25 | -128.57%-0.16 | -71.16%0.62 | -58.48%0.71 | -42.73%0.63 | -13.85%0.56 | 4.88%2.15 |
| Diluted earning per share | 156.25%0.09 | -60.66%0.24 | -130.00%-0.21 | -140.32%-0.25 | -128.57%-0.16 | -71.36%0.61 | -58.82%0.7 | -43.12%0.62 | -12.50%0.56 | 4.41%2.13 |
| Other composite income | 113.29%68.68K | 228.55%621.35K | 42.82%1.2M | 279.64%1.51M | -2,184.58%-516.67K | -219.53%-483.37K | 2,320.36%842.14K | 768.15%399K | -152.80%-22.62K | 72.99%-151.27K |
| Other composite income of parent company owners | 113.29%68.68K | 228.55%621.35K | 42.82%1.2M | 279.64%1.51M | -2,184.58%-516.67K | -219.53%-483.37K | 2,320.36%842.14K | 768.15%399K | -152.80%-22.62K | 72.99%-151.27K |
| Add:Adjusted items effecting composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
| Total composite income | 154.60%3.77M | -61.13%8.88M | -129.03%-7.14M | -138.88%-8.68M | -141.16%-6.91M | -64.56%22.85M | -51.94%24.6M | -32.31%22.32M | -13.84%16.78M | 6.00%64.47M |
| Total composite income of parent company owners | 154.60%3.77M | -61.13%8.88M | -129.03%-7.14M | -138.88%-8.68M | -141.16%-6.91M | -64.56%22.85M | -51.94%24.6M | -32.31%22.32M | -13.84%16.78M | 11,611.27%64.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- | -- | -- |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg